Radioiodine or surgery for toxic thyroid adenoma: Dissecting an important decision - A cost-effectiveness analysis

Thyroid

Volumn 14, Issue 11, 2004, Pages 933-945

  Vidal Trecan, Gwenaëlle M ^a   Stahl, James E ^b   Eckman, Mark H ^c  

^a Univ René Descartes ^*  (France)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; FEMALE; HEALTH CARE SYSTEM; HUMAN; LOW DRUG DOSE; PRIORITY JOURNAL; QUALITY OF LIFE; SUBTOTAL THYROIDECTOMY; THYROID ADENOMA;

EID: 10044243877     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2004.14.933     Document Type: Article

References (94)

1. Hay ID, Morris JC 1996 Toxic adenoma and toxic multi-nodular goiter. In: Braverman LE, Utiger RD (eds). Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. Lippincott-Raven, Philadelphia, pp. 566-713.
2. Cooper DS 1984 Antithyroid drugs. N Engl J Med 311:1353-1362.
3. Franklyn JA 1994 The management of hyperthyroidism [published erratum appears in N Engl J Med 1994;331:559]. N Engl J Med 330:1731-1738.
4. Hermus AR, Huysmans DA 1998 Treatment of benign nodular thyroid disease. N Engl J Med 338:1438-1447.
5. O'Brien T, Gharib H, Suman VJ, van Heerden JA 1992 Treatment of toxic solitary thyroid nodules: Surgery versus radioactive iodine. Surgery 112:1166-1170.
6. Giuffrida D, Gharib H 1995 Controversies in the management of cold, hot, and occult thyroid nodules. Am J Med 99:642-650.
7. Bockisch A, Jamitzky T, Derwanz R, Biersack HJ 1993 Optimized dose planning of radioiodine therapy of benign thyroidal diseases [see comments]. J Nucl Med 34:1632-1638.
8. Cooper DS 1996 Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD (eds). Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. Lippincott-Raven, Philadelphia, pp. 713-734.
9. Farrar JJ, Toft AD 1991 Iodine-131 treatment of hyperthyroidism: Current issues. Clin Endocrinol (Oxf) 35:207-212.
10. Vidal-Trecan GM, Stahl JE, Durand-Zaleski I 2002 Managing toxic thyroid adenoma: A cost-effectiveness analysis. Eur J Endocrinol 146:283-294.
11. Miller JM, Block MA 1968 The autonomous functioning thyroid nodule: therapeutic considerations. Arch Surg 96:386-393.
12. Blum M, Shenkman L, Hollander C 1975 The autonomous nodule of the thyroid: correlation of patient age, nodule size and functional status. Am J Med Sci 269:43-50.
13. Hamburger JI 1975 Solitary autonomously functioning thyroid lesions. Diagnosis, clinical features and pathogenetic considerations. Am J Med 58:740-748.
14. Molnar GD, Wilber RD, Lee RE, Woolner LB, Keating FR 1965 On the hyperfunctioning solitary thyroid nodule. Mayo Clin Proc 40:665-684.
15. Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM, Becker DV 1974 Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: A report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab 38:976-998.
16. McCormack KR, Sheline GE 1967 Long-term studies of solitary autonomous thyroid nodules. J Nucl Med 8:701-708.
17. Garnier H, Bacourt F, Boucaut P, Fraioli JP, Hannoun L 1978 [The surgical treatment of toxic nodular goitres (author's transl)]. Chirurgie 104:727-731.
18. Eyre-Brook IA, Talbot CH 1982 The treatment of autonomous functioning thyroid nodules. Br J Surg 69:577-579.
19. Proye C, Lagache G, Patoir A, Letendart J, Gregoire M, Houcke M, et al 1980 [Thyroid autonomous nodule. Surgical treatment and post-operative outcome. Retrospective study of 102 cases (author's transl)]. Ann Chir 34:5-10.
20. Melliere D, Scattolini G, Germain V, Salvat A 1980 [Outcome of surgery in 300 cases of hyperthyroidism, including 40 with cardiotoxicity (author's transl)]. Nouv Presse Med 9:2121-2124.
21. Peix JL, Zabot JM 1988 [Complications and sequelae of thyroid surgery]. Presse Med 17:1749-1753.
22. Dulac JP, Soustelle J, Bouchet A 1983 [Surgical therapy of toxic thyroid adenoma. Study of 630 cases]. Lyon Chir 79:161-166.
23. Fleisher LA 2000 Risk of anesthesia. In: Miller RD (ed) Anesthesia. Churchill Livingstone, Philadelphia, pp. 795-823.
24. Clerc J, Dagousset F, Izembart M, Jais JP, Heshmati HM, Alcais A, Chevalier A, Leger AF, Barritault L 1995 Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity [see comments]. J Nucl Med 36:217-223.
25. Glinoer D, Vereist J 1996 [Use of 131 iodine for the treatment of hyperthyroidism in adults]. Ann Endocrinol (Paris) 57:177-185.
26. Goldstein R, Hart IR 1983 Follow-up of solitary autonomous thyroid nodules treated with 1311. N Engl J Med 309:1473-1476.
27. Ross DS, Ridgway EC, Daniels GH 1984 Successful treatment of solitary toxic thyroid nodules with relatively low-dose iodine-131, with low prevalence of hypothyroidism. Ann Intern Med 101:488-490.
28. Horst W, Rosler H, Schneider C, Labhart A 1967 306 cases of toxic adenoma: clinical aspects, findings in radioiodine diagnostics, radiochromatography and histology: Results of 131-I and surgical treatment. J Nucl Med 8:515-528.
29. Vallee G, Doumith R 1974 [Results of the treatment of toxique thyroid adenomas by 131-I (author's transl)]. Ann Endocrinol (Paris) 35:45-47.
30. Fontana B, Curti G, Biggi A, Fresco G 1980 The incidence of hypothyroidism after radioactive iodine (131I) therapy for autonomous hyperfunctioning thyroid nodule evaluated by means of life-table method. J Nucl Med Allied Sci 24:85-91.
31. Huysmans DA, Corstens FH, Kloppenborg PW 1991 Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine [see comments]. J Nucl Med 32:27-30.
32. 131I treatment of diffuse and nodular toxic goitre with and without antithyroid agents. Acta Endocrinol (Copenh) 99:517-521.
33. Hegedus L, Veiergang D, Karstrup S, Hansen JM 1986 Compensated 131I-therapy of solitary autonomous thyroid nodules: Effect on thyroid size and early hypothyroidism. Acta Endocrinol (Copenh) 113:226-232.
34. Ratcliffe GE, Cooke S, Fogelman I, Maisey MN 1986 Radioiodine treatment of solitary functioning thyroid nodules. Br J Radiol 59:385-387.
35. Hoffman DA, McConahey WM, Fraumeni JF Jr, Kurland LT 1982 Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol 11:218-224.
36. Holm LE, Dahlqvist I, Israelsson A, Lundell G 1980 Malignant thyroid tumors after iodine-131 therapy: A retrospective cohort study. N Engl J Med 303:188-191.
37. Holm LE, Lundell G, Israelsson A, Dahlqvist I 1982 Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism. J Nucl Med 23:103-107.
38. Holm LE, Hall P, Wiklund K, Lundell G, Berg G, Bjelkengren G, et al. 1991 Cancer risk after iodine-131 therapy for hyperthyroidism [see comments]. J Natl Cancer Inst 83:1072-1077.
39. Ron E, Doddy MM, Becker DV, Brill AB, Curtis RE, Goldman MB, et al 1998 Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group [see comments]. JAMA 280:347-355.
40. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, Boyle P 1999 Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 353:2111-2115.
41. Tajiri J, Noguchi S, Murakami T, Murakami N 1990 Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring [see comments]. Arch Intern Med 150:621-624.
42. Petersen K, Bengtsson C, Lapidus L, Lindstedt G, Nystrom E 1990 Morbidity, mortality, and quality of life for patients treated with levothyroxine [see comments]. Arch Intern Med 150:2077-2081.
43. Leese GP, Jung RT, Guthrie C, Waugh N, Browning MC 1992 Morbidity in patients on L-thyroxine: A comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol (Oxf) 37:500-503.
44. Mandel SJ, Brent GA, Larsen PR 1993 Levothyroxine therapy in patients with thyroid disease. Ann Intern Med 119:492-502.
45. Hamburger J 1983 The autonomously functioning thyroid adenoma: Clinical consideration [editorial]. N Engl J Med 309:1512-1513.
46. Larsen P, Ingbar SH 1992 The thyroid gland. In: Wilson J, Foster D (eds) Williams Textbook of Endocrinology. W.B. Saunders Company, Philadelphia, pp. 357-488.
47. Thomas CG Jr, Croom RD III 1987 Current management of the patient with autonomously functioning nodular goiter. Surg Clin North Am 67:315-328.
48. Lau J, Kassirer JP, Pauker SG 1983 Decision Maker 3.0. Improved decision analysis by personal computer. Med Decis Making 3:39-43.
49. Pauker SG, Kassirer JP 1981 Clinical decision analysis by personal computer. Arch Intern Med 141:1831-1837.
50. Pauker SG, Kassirer JP 1987 Decision analysis. N Engl J Med 316:250-258.
51. Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, Braverman LE, Clark OH, McDougall IR, Ain KV, Dorfman SG 1996 Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 156:2165-2172.
52. Cooper DS, Goldminz D, Levin AA, Ladenson PW, Daniels GH, Molitch ME, Ridgway EC 1983 A granulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med 98:26-29.
53. Tamai H, Takaichi Y, Morita T, Komaki G, Matsubayashi S, Kuma K, Walter RM Jr, Kumagai LF, Nagataki S 1989 Methimazole-induced agranulocytosis in Japanese patients with Graves' disease. Clin Endocrinol (Oxf) 30:525-530.
54. National Center for Health Statistics. Vital Statistics in the United States, Mortality, Part A. Public Health Service Washington, D.C., 1990.
55. Tengs TO, Wallace A 2000 One thousand health-related quality-of-life estimates. Med Care 38:583-637.
56. Department of Health and Human Services 2002 Medicare Provider Analysis and Review of Short Stay Hospitals. U.S. Centers for Medicaid and Medicare Services, Hyattsville, M.D. www.cms.hhs.gov
57. Department of Health and Human Services 2002 National Physician Fee Schedule Relative Value File. U.S. Centers for Medicaid and Medicare Services, Hyattsville, M.D. www.cms.hhs.gov
58. Department of Health and Human Services 2002 Clinical Lab Fee Schedule. U.S. Centers for Medicaid and Medicare Services, Hyattsville, M.D. www.cms.hhs.gov
59. Drug Topics Red Book 2002 Medical Economics: Montvale, NJ.
60. Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G, Greenspan FS, McDougall IR, Nikolai TF 1995 Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association [see comments]. JAMA 273:808-812.
61. Gold M, Siegel J, Russell L, Weinstein M 1996 Cost-effectiveness in health and medicine. Oxford University Press. New York, NY.
62. Weinstein MC, Stason WB 1977 Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 296:716-721.
63. Drummond M, Stoddart G, Torrance G. Cost-utility analysis. In: Drummond M, Stoddart G, Torrance GW (eds) Methods for Economic Evaluation of Health Care Programmes. Oxford, Oxford University Press, pp. 112-148.
64. Anonymous 1982 The thyroid nodule. Ann Intern Med 96:221-232.
65. Bona M, Santini F, Rivolta G, Grossi E, Grilli R 1998 Cost effectiveness of screening for subclinical hypothyroidism in the elderly. A decision-analytical model. Pharmacoeconomics 14:209-216.
66. Danese MD, Powe NR, Sawin CT, Ladenson PW 1996 Screening for mild thyroid failure at the periodic health examination: A decision and cost-effectiveness analysis [see comments]. JAMA 276:285-292.
67. Esnaola NF, Cantor SB, Sherman SI, Lee JE, Evans DB 2001 Optimal treatment strategy in patients with papillary thyroid cancer: A decision analysis. Surgery 130:921-930.
68. Lenne X, Allenet B, Laurent P, Lebrun T, Wemeau JL 1999 [Economic evaluation of the value of early diagnosis and management of hypothyroidism in hypercholesterolemia]. Ann Endocrinol (Paris) 60:398-407.
69. Sisson JC, Bartold SP, Bartold SL 1978 The dilemma of the solitary thyroid nodule: resolution through decision analysis. Semin Nucl Med 8:59-71.
70. Thompson MS, McNeil BJ, Ganatra RD, Larsen PR, Adelstein SJ 1981 Cost-effectiveness of screening for hypo- and hyperthyroidism in India. Med Decis Making 1:44-58.
71. Wong JB, Kaplan MM, Meyer KB, Pauker SG 1990 Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective. Endocrinol Metab Clin North Am 19:741-760.
72. Molitch M, Beck J, Dreisman M, Gottlieb J, Pauker S 1984 The cold thyroid nodule: An analysis of diagnostic and therapeutic options. Endocr Rev 5:185-199.
73. Sisson J, Bartold S, Bartold S 1978 The dilemma of the solitary thyroid nodule: resolution through decision analysis. Semin Nucl Med 8:59-71.
74. Wong J, Kaplan M, Meyer B, Pauker S 1990 Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. Endocrinol Metabol Clin 19:741-759.
75. Blondeau P 1991 Chirurgie de l'hyperthyroïdie (Réflexions thérapeutiques et nosologiques. A propos d'une série personnelle de 2385 interventions). Bull Acad Nat Med (Paris) 175:1065-1075.
76. Pacini F, Elisei R, Di Coscio GC, Anelli S, Macchia E, Concetti R, Miccoli P, Arganini M, Pinchera A 1988 Thyroid carcinoma in thyrotoxic patients treated by surgery. J Endocrinol Invest 11:107-112.
77. Robinson E, Horn Y, Hochmann A 1966 Incidence of cancer in thyroid nodules. Surg Gynecol Obstet 123:1024-1026.
78. Rieger R, Pimpl W, Money S, Rettenbacher L, Galvan G 1989 Hyperthyroidism and concurrent thyroid malignancies. Surgery 106:6-10.
79. Terzioglu T, Tezelman S, Onaran Y, Tanakol R 1993 Concurrent hyperthyroidism and thyroid carcinoma. Br J Surg 80:1301-1302.
80. Tourniaire J 1971 [Unrecognized etiological aspects of toxic thyroid adenoma (toxic adenoma on a thyroidectomy stump, toxic adenoma and cancer)]. Lyon Med 225:1215-1221.
81. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ 1992 Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50-year period. Surgery 112:1139-1146.
82. Franssila KO, Harach HR. Occult papillary carcinoma of the thyroid in children and young adults. A systemic autopsy study in Finland. Cancer 58:715-719.
83. Harach HR, Franssila KO, Wasenius VM 1985 Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 56:531-538.
84. Laupacis A, Feeny D, Detsky AS, Tugwell PX 1992 How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 146:473-481.
85. Patwardhan N, Cataldo T, Braverman LE 1995 Surgical management of the patient with papillary cancer. Surg Clin North Am 75:449-464.
86. Rosove MH 1977 Agranulocytosis and antithyroid drugs. West J Med 126:339-343.
87. Cannoni M, Demard F 1995 L'expérience des rapporteurs. Etude statistique: les données générales et les complications. In: Cannoni M, Demard F (eds) Les nodules thyroïdiens du diagnostic à la chirurgie. Arnette Paris pp. 237-244.
88. Lennquist S 1987 The thyroid nodule. Diagnosis and surgical treatment. Surg Clin North Am 67:213-232.
89. Melliere D, Berrahal D, Hindie E, Jeanguillaume C, Becquemin JP, Lange F 2000 [Surveillance after treatment of differentiated thyroid cancers]. Ann Chir 125:856-860.
90. Tanaka K, Sonoo H, Yamamoto Y, Udagawa K, Arime I, Kunisue H, Yamamoto S, Kurebayashi J, Shimozuma K 1999 Analyses of the outcome of locally invasive papillary thyroid carcinomas. Thyroid 9:1017-1022.
91. Lerch H, Schober O, Kuwert T, Saur HB 1997 Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 15:2067-2075.
92. Shaha AR, Shah JP, Loree TR 1996 Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 3:534-538.
93. Hay ID, Grant CS, Taylor WF, McConahey WM 1987 Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088-1095.
94. Burman KD, Ringel MD, Wartofsky L 1996 Unusual types of thyroid neoplasms. Endocrinol Metab Clin North Am 25:49-68.